TGFB1 and renal fibrosis: Considering that chronic inflammation is well recognized to participate in the progression of renal fibrosis [11, 14–16], these results suggest that, in addition to the inhibition of TGF-β/Smad signaling, the enhanced immunosuppressive abilities of hypoxia-preconditioned MSCs are involved in both anti-inflammatory and anti-fibrotic effects.